A wide range of drugs can make you nod off, from opioids and benzodiazepines to common over-the-counter allergy pills and prescription muscle relaxants. The mechanism varies by drug class, but the shared thread is that these substances dampen activity in the brain and central nervous system in ways that blur the line between drowsiness and dangerous sedation. In the case of opioids, “nodding off” carries a specific and alarming meaning that goes well beyond feeling sleepy, one that has become more dangerous in recent years as the drug supply has changed.
Opioids and the Particular Danger of “Nodding”
When people talk about drugs making you nod off, they often mean opioids. The characteristic head-bobbing, eyes-half-closed state that opioid users call “nodding” looks like dozing but is something more precarious. It represents a fluctuating state of consciousness driven by the drug’s suppression of breathing. As breathing slows, oxygen levels in the blood drop and carbon dioxide builds up. Normally your brain would jolt you awake, but opioids blunt that protective reflex. The result is a person drifting in and out of a state that can slide from sedation into fatal respiratory failure with very little warning.1PubMed Central. Opioid-Induced Nodding-Not a Nice Nap
This distinction matters because bystanders, and sometimes users themselves, treat nodding as harmless. It is not. The gap between nodding and a full overdose has narrowed considerably in the fentanyl era, where the potency of a given dose is unpredictable. Respiratory depression that starves the brain of oxygen is the primary mechanism behind opioid overdose deaths, whether the drug involved is heroin, prescription painkillers, or illicit fentanyl.2PubMed Central. Respiratory depression and brain hypoxia induced by opioid drugs: Morphine, oxycodone, heroin, and fentanyl
There is also growing evidence that even “non-fatal” nodding episodes can do lasting damage. Repeated bouts of oxygen deprivation appear to contribute to cumulative brain injury, including shrinkage of the hippocampus (the brain region central to memory) and persistent cognitive problems. Researchers describe this as hypoxic-ischemic brain injury, and it can accumulate over time with repeated overdose events that may not look dramatic from the outside.1PubMed Central. Opioid-Induced Nodding-Not a Nice Nap
Prescription and Over-the-Counter Sedating Drugs
Opioids get the most attention, but plenty of other medications make people drowsy enough to nod off, sometimes unexpectedly. Understanding which ones carry this risk helps you anticipate side effects, whether you are taking a prescribed medication or reaching for something off the pharmacy shelf.
First-Generation Antihistamines
Diphenhydramine (Benadryl) and similar older allergy drugs are among the most commonly used sedating substances in the world. They cross freely into the brain, unlike newer antihistamines, and their sedating effect is well established at normal doses. The brain has a gatekeeper system that pumps many drugs back out before they can affect neurons, but first-generation antihistamines bypass this mechanism, which is why they make you drowsy while second-generation options like loratadine and cetirizine generally do not.3PubMed Central. H1 antihistamines: current status and future directions 4PubMed. Assessment of the first and second generation antihistamines brain penetration and role of P-glycoprotein
Because they are cheap and available without a prescription, first-generation antihistamines are widely misused as sleep aids. This is worth being cautious about. They impair cognitive function and psychomotor performance even at recommended doses, and the sedation they produce is pharmacologically different from natural sleep.
Benzodiazepines and Related Sleep Medications
Benzodiazepines like alprazolam (Xanax), diazepam (Valium), and clonazepam (Klonopin) work by enhancing the effect of GABA, the brain’s main inhibitory chemical messenger. They are prescribed for anxiety, seizures, and insomnia, and their sedating potential is well known. What catches people off guard is how long the sedation can persist. A benzodiazepine taken at bedtime can still impair your ability to drive a car the next morning or even into the afternoon, depending on the dose and the specific drug’s duration in the body.5PubMed. Residual effects of sleep medication on driving ability
Non-benzodiazepine sleep drugs like zopiclone produce similar next-day sedation and driving impairment, despite being marketed as shorter-acting alternatives.5PubMed. Residual effects of sleep medication on driving ability
Muscle Relaxants and Nerve Pain Drugs
Tizanidine, a muscle relaxant prescribed for spasticity and pain, works through a mechanism that also suppresses arousal centers in the brain. The resulting sedation is strong enough that some patients deliberately take it at bedtime for help with sleep, though drowsiness during the day is a common complaint at higher doses.6PubMed Central. Tizanidine: Advances in Pharmacology & Therapeutics and Drug Formulations
Gabapentinoids, a class that includes gabapentin and pregabalin, are prescribed for nerve pain, seizures, and sometimes anxiety. Both can cause significant drowsiness, dizziness, and fatigue. When prescribed together, which does happen despite the overlap, these effects intensify considerably and can include unsteadiness and difficulty concentrating.7PubMed Central. Potential Adverse Consequences of Combination Therapy with Gabapentin and Pregabalin
Barbiturates and Newer Sedatives
Barbiturates were the dominant sedatives for much of the twentieth century, used for everything from anxiety and insomnia to schizophrenia treatment. Their steep decline came because of a serious safety problem: the gap between a therapeutic dose and a lethal dose was small, and physical dependence developed quickly. Barbiturates were largely replaced by benzodiazepines starting in the 1960s, though a few barbiturates remain in use for anesthesia and certain types of epilepsy.8PubMed Central. The history of barbiturates a century after their clinical introduction
Some newer sedating drugs work through similar brain pathways but with more targeted mechanisms. Brexanolone, for example, is a neurosteroid approved to treat postpartum depression that acts on GABA receptors. Its sedating potential is so significant that it requires administration as a continuous intravenous infusion in a monitored healthcare setting, with specific safety protocols in place because of the risk of sudden loss of consciousness.9PubMed Central. Brexanolone, a First-In-Class Neurosteroid Medication: Mechanism of Action, Clinical, and Translational Science
Why Mixing Substances Multiplies the Danger
Many of the worst outcomes from sedating drugs happen not from one substance alone but from combinations. Opioids taken alongside benzodiazepines, alcohol, or other central nervous system depressants create compounding effects on breathing and consciousness. Both opioids and benzodiazepines suppress breathing through partially overlapping brain pathways, so using them together produces a defined increase in overdose rates and death.10National Institute on Drug Abuse. Benzodiazepines and Opioids 11PubMed Central. Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use
The risks extend beyond respiratory failure. When a person becomes deeply sedated from multiple substances and stays immobile for hours, the sustained pressure on muscles can trigger a condition called rhabdomyolysis, in which muscle tissue breaks down and floods the bloodstream with proteins that can damage the kidneys. Case reports have linked this to combinations of opioids with benzodiazepines or pregabalin, where the person was sedated deeply enough and long enough for the positional damage to occur.12PubMed Central. Cervical Myelopathy Associated With Deep Neck Muscle Rhabdomyolysis After Polysubstance Abuse: A Case Report
This is one reason why the opioid-era advice to “never use alone” exists. A person who nods off and stays in one position for hours may sustain serious injury even if their breathing remains adequate.
Adulterants That Make Street Drugs More Sedating
The illicit drug supply has become more sedating in recent years, partly because of substances being added to opioids that users may not know about. Xylazine and medetomidine are veterinary sedatives that have appeared increasingly in fentanyl and other street drugs across the United States. Both are alpha-2 adrenergic receptor agonists, a class of drug that suppresses the brain’s arousal systems through a different pathway than opioids.
The practical problem is that naloxone (Narcan), the standard opioid overdose reversal drug, does not work on these substances because they do not act on opioid receptors. When someone overdoses on a fentanyl-xylazine mixture, naloxone may partially restore breathing by blocking the opioid component, but the sedation and respiratory depression from the xylazine remain. This has contributed to an increase in fatal overdoses.13Physiology. Dual Opioid and Alpha-2 Adrenergic Receptor Blockade Prevents Respiratory Depression from Fentanyl–Xylazine and Fentanyl-Dexmedetomidine Exposure
In response, xylazine has been classified as an emerging public health threat, and more than half of U.S. state-level policy proposals on the topic have focused on scheduling it as a controlled substance.14PubMed. A content analysis of legal policy responses to xylazine in the illicit drug supply in the United States Whether scheduling is the right response is debated. Some researchers have argued that criminalizing possession of xylazine could discourage people who use drugs from seeking medical help, undermining the very harm reduction efforts that save lives.15PubMed Central. A Content Analysis of Xylazine-associated Stigma in Web-based Media Driven by the Zombie Term and Stigmatizing Imagery
Next-Day Impairment and Driving
For people taking sedating drugs as prescribed, one of the most relevant safety concerns is what happens the morning after. Sleep medications and anti-anxiety drugs do not always wear off by the time you get behind the wheel. On-the-road driving studies have shown that benzodiazepine hypnotics can significantly impair driving ability the morning after a bedtime dose, and in some cases the impairment persists into the afternoon, more than sixteen hours after the drug was taken.5PubMed. Residual effects of sleep medication on driving ability
A systematic review and meta-analysis of sleep medication effects on driving confirmed that residual effects on driving safety are common across the class, not limited to one or two outlier drugs.16PubMed. Residual effects of medications for sleep disorders on driving performance: A systematic review and network meta-analysis of randomized controlled trials Specific research on alprazolam found that even a bedtime dose produced measurable next-day impairment on driving simulators, with higher doses causing lane departures and speed instability that matched the impairment of taking the drug during the day.17PubMed Central. Residual Next-Day Effects of Alprazolam on Psychomotor Performance and Simulated Driving in Healthy Normal Adults
The implication is straightforward: if you take a sedating medication at night, you should not assume you are unimpaired the next day just because you feel awake. The subjective feeling of alertness often returns before objective performance does. This applies to driving, operating machinery, and any task that requires fast reaction times.
Who Misuses Sedatives and Why
People misuse sedating drugs for different reasons depending on their age. In a large U.S. population study, the most common motivation for tranquilizer and sedative misuse among adults 65 and older was self-treatment: they wanted help sleeping or relaxing, and the rate of this self-treatment motivation reached roughly 83% in that age group. Among adolescents aged 12 to 17, the pattern was nearly reversed: about two-thirds reported recreational motives.18PubMed Central. Prescription Tranquilizer/Sedative Misuse Motives Across the U.S. Population
This distinction matters for intervention. An older adult misusing a benzodiazepine to sleep is dealing with a different problem than a teenager taking one to get high, even though the physical risks overlap. Any misuse of tranquilizers or sedatives was associated with higher rates of substance use disorders, mental health conditions, and physical health problems, but recreational misuse carried the steepest risks. The same study also found that among adults over 50, the link between sedative misuse and mental health difficulties was especially strong.18PubMed Central. Prescription Tranquilizer/Sedative Misuse Motives Across the U.S. Population
Tapering Off Sedating Medications Safely
If you are on a sedating medication and want to reduce or stop it, the single most important thing to know is: do not quit abruptly. Benzodiazepines in particular can cause dangerous withdrawal symptoms, including seizures, if stopped suddenly after regular use. Current clinical guidelines recommend gradual dose reductions, typically starting at 5 to 10% per reduction, with the pace generally not exceeding 25% every two weeks. Some patients benefit from switching to a longer-acting benzodiazepine for the taper, which smooths out the withdrawal curve.19PubMed Central. Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits
A systematic review covering about 11,000 older adults found that structured gradual tapering was both safe and the most effective strategy for discontinuing benzodiazepines, with withdrawal symptoms typically mild and transient and serious adverse events rare. Other approaches, such as patient education programs or clinician-led reviews, were less consistently effective on their own.20PubMed. Safety and effectiveness of strategies to deprescribe chronic benzodiazepine receptor agonist use in older adults: a systematic review
If the reason you are taking a sedative is insomnia, there are evidence-based alternatives that do not carry the same risks. Cognitive behavioral therapy for insomnia, or CBT-I, is recommended as the first-line treatment for chronic insomnia. It works by restructuring the sleep habits and thought patterns that perpetuate sleeplessness, and it has a large evidence base behind it.21PubMed Central. Cognitive Behavioral Therapy for Insomnia (CBT-I): A Primer The American Academy of Sleep Medicine recommends combining CBT-I with medication over using medication alone for chronic insomnia, positioning behavioral treatment as the foundation rather than an optional add-on.22PubMed Central. Combination treatment for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline
Newer programs are beginning to integrate medication tapering directly into CBT-I treatment, so that patients can reduce their reliance on sleep drugs while simultaneously building the skills to sleep without them. Early results suggest this combined approach is both feasible and effective, including when delivered by telehealth.23PubMed. Outcomes from a combined cognitive behavioral therapy for insomnia (CBT-I) and sleep-related medication and substance use reduction treatment
Harm Reduction When Drug Use Continues
For people who use opioids or other sedating drugs and are not ready or able to stop, harm reduction strategies can reduce the risk of death and serious injury. These strategies include testing drugs for contaminants like fentanyl and xylazine before use, carrying naloxone, never using alone, and accessing overdose prevention services.24PubMed. Harm Reduction Strategies for People Who Use Drugs
The presence of xylazine and similar adulterants in the drug supply makes testing especially important. Fentanyl test strips are widely available and inexpensive, and xylazine test strips have been introduced in many areas. Since naloxone will not reverse xylazine’s effects, knowing what is in a substance before using it can change how a person and their companions prepare for an emergency. If someone who has used drugs stops responding, calling emergency services remains critical even if naloxone has been administered, because the sedation may have a component that naloxone cannot touch.
One underappreciated piece of harm reduction is body positioning. As noted earlier, prolonged immobility during deep sedation can cause muscle breakdown and nerve compression injuries. If you are with someone who has nodded off and is still breathing adequately, repositioning them periodically and placing them in the recovery position (on their side, with their airway clear) can reduce the risk of both aspiration and positional injuries.